Renaissance Technologies’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Buy |
181,388
+34,800
| +24% | +$708K | ﹤0.01% | 1714 |
|
|
2025
Q1 | $2.66M | Buy |
146,588
+10,000
| +7% | +$182K | ﹤0.01% | 1818 |
|
|
2024
Q4 | $3.45M | Buy |
+136,588
| New | +$3.45M | 0.01% | 1680 |
|
|
2024
Q3 | – | Sell |
-42,788
| Closed | -$1.58M | – | 3563 |
|
|
2024
Q2 | $1.58M | Sell |
42,788
-269,682
| -86% | -$9.98M | ﹤0.01% | 2022 |
|
|
2024
Q1 | $13.1M | Buy |
+312,470
| New | +$13.1M | 0.02% | 848 |
|
|
2022
Q4 | – | Sell |
-25,888
| Closed | -$728K | – | 4142 |
|
|
2022
Q3 | $728K | Buy |
+25,888
| New | +$728K | ﹤0.01% | 2692 |
|
|
2021
Q4 | – | Sell |
-161,276
| Closed | -$8.71M | – | 3933 |
|
|
2021
Q3 | $8.71M | Sell |
161,276
-202,751
| -56% | -$10.9M | 0.01% | 1118 |
|
|
2021
Q2 | $12.2M | Sell |
364,027
-177,400
| -33% | -$5.93M | 0.02% | 1040 |
|
|
2021
Q1 | $11.2M | Sell |
541,427
-507,400
| -48% | -$10.5M | 0.01% | 1125 |
|
|
2020
Q4 | $18.4M | Sell |
1,048,827
-687,848
| -40% | -$12.1M | 0.02% | 805 |
|
|
2020
Q3 | $25.8M | Buy |
1,736,675
+99,500
| +6% | +$1.48M | 0.03% | 616 |
|
|
2020
Q2 | $21.3M | Buy |
1,637,175
+466,988
| +40% | +$6.07M | 0.02% | 785 |
|
|
2020
Q1 | $1.94M | Buy |
1,170,187
+54,819
| +5% | +$91K | ﹤0.01% | 2066 |
|
|
2019
Q4 | $2.49M | Buy |
1,115,368
+89,083
| +9% | +$199K | ﹤0.01% | 2212 |
|
|
2019
Q3 | $2.19M | Buy |
1,026,285
+114,000
| +12% | +$243K | ﹤0.01% | 2236 |
|
|
2019
Q2 | $2.45M | Buy |
912,285
+367,179
| +67% | +$984K | ﹤0.01% | 2223 |
|
|
2019
Q1 | $2.68M | Buy |
545,106
+102,625
| +23% | +$505K | ﹤0.01% | 2162 |
|
|
2018
Q4 | $1.31M | Buy |
442,481
+86,241
| +24% | +$256K | ﹤0.01% | 2446 |
|
|
2018
Q3 | $2.41M | Buy |
356,240
+74,861
| +27% | +$506K | ﹤0.01% | 2185 |
|
|
2018
Q2 | $2.13M | Buy |
281,379
+271,085
| +2,633% | +$2.05M | ﹤0.01% | 2234 |
|
|
2018
Q1 | $360K | Buy |
+10,294
| New | +$360K | ﹤0.01% | 3007 |
|
|
2017
Q4 | – | Sell |
-13,414
| Closed | -$575K | – | 3349 |
|
|
2017
Q3 | $575K | Sell |
13,414
-9,827
| -42% | -$421K | ﹤0.01% | 2750 |
|
|
2017
Q2 | $861K | Sell |
23,241
-90,621
| -80% | -$3.36M | ﹤0.01% | 2610 |
|
|
2017
Q1 | $6.17M | Buy |
113,862
+33,881
| +42% | +$1.83M | 0.01% | 1540 |
|
|
2016
Q4 | $4.25M | Sell |
79,981
-3,900
| -5% | -$207K | 0.01% | 1775 |
|
|
2016
Q3 | $5.08M | Buy |
83,881
+32,094
| +62% | +$1.94M | 0.01% | 1591 |
|
|
2016
Q2 | $3.41M | Sell |
51,787
-2,435
| -4% | -$160K | 0.01% | 1862 |
|
|
2016
Q1 | $3.07M | Buy |
+54,222
| New | +$3.07M | 0.01% | 1957 |
|